Notable 52-Week Highs and Lows of the Day 11/09: LLNW, SLW, LDK, LOGI High; DF, ANDS Low

FREE Breaking News Alerts from StreetInsider.com!

LLNW Hot Sheet

Overall Analyst Rating:
NEUTRAL (

This report is an intraday check of some of the more notable stocks that have hit a 52-week high or low so far today.

52-Week High:

Limelight Networks, Inc. (Nasdaq: LLNW) high of $8.97. Jumping higher today as reports circulating around the web have them, as well as Level 3 (Nasdaq: LVLT), stealing Netflix (Nasdaq: NFLX) business away from Akamai (Nasdaq: AKAM). The rumors have been all but put to rest by Limelight and Netflix, but Limelight's shares are still reacting.
Silver Wheaton Corp. (NYSE: SLW) high of $37.20. Are investors now "Silver Bugs"? Possibly, as gold may have been getting too much attention over the past year, driving some to seek similar safety with a less-publicized metal. December 10 silver contracts, the most actively traded, are up about 1.7% today, pushing Silver Wheaton higher right along with it.
LDK Solar Co., Ltd. (NYSE: LDK) high of $15.10. Seeing upside today following a third quarter earnings report with an EPS of $0.72 and revs of $675.6 million, versus the consensus EPS of $0.41 and $631.81 million in sales. LDK sees Q410 sales of $710 - $750 million, versus the consensus of $593 million, with shipments of 580 - 600-MW. Also is looking for FY11 sales of $2.9 - $3.3 billion, versus $2.11 billion consensus, and shipments of 2.5 - 2.8-GW. Also seeing a boost from SolarFun (Nasdaq: SOLF), which reported strong Q310 results as well today.
Logitech International SA (Nasdaq: LOGI) high of $23.29. Though a partner in Google (Nasdaq: GOOG) TV, Logitech is more likely seeing upside today following the filing of its 10-Q report after the market yesterday, giving investors and analysts a closer look at what happened through the quarter.

52-Week Low:

Dean Foods Co. (NYSE: DF) low of $8.50. Lower today after missing third quarter estimates completely. Dean reported an adjusted EPS of $0.13, shy of the $0.21 consensus. Revs for the quarter came in at $3.05 billion, compared to the consensus of $3.04 billion. Additionally, the company sees a Q410 EPS of $0.13 - $0.18, well below the consensus of $0.27.
Anadys Pharmaceuticals Inc. (Nasdaq: ANDS) low of $1.24. Anadys reported a third quarter loss of $0.11 per share, missing views by 2 cents. No revs were stated for the pharma. Notably, Canaccord Genuity kept their Buy rating on the shares, and has a price target of $2.50.

Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!